The Global Y 27632 dihydrochloride market is expected to grow at a significant CAGR during the forecast period. Y-27632 dihydrochloride is an orally active, ATP-competitive inhibitor of Rock-I and Rock-II, with Kis of 220 and 300 nM, respectively. Apoptosis is induced by Y-27632 dihydrochloride. Y-27632 dihydrochloride primes human induced pluripotent stem cells (hIPSCs) towards mesendodermal lineage differentiation through epithelial-mesenchymal transition. 

It is used to increase the survival rate of cryopreserved human embryonic stem (hES) cells and iPSC. To convert fibroblasts to mature neurons, it is used with CHIR99021, RepSox, Forskolin, SP 600125, Go 6983, and VPA. In addition, it improves naive human pluripotent stem cell growth and viability when naive cells are generated from primed ESCs (epiblast stem cells) and iPSCs (induced pluripotent stem cells) using naive human stem cells medium (NHSM). 

According to the Department of Health United States, the number of infant mortalities (Infants aged < 1 year is 342. The number of neonatal deaths (Infants aged < 28 days) is 230, and the number of postneonatal deaths (infants aged 28 days to < 1 year) is 112. Infant mortality rate per 1,000 live births is 5.1, Neonatal mortality rate per 1,000 live births 3.4, Postneonatal mortality rate per 1,000 live births 1.7, Fetal mortality rate per 1,000 live births and fetal mortalities is 5.1. This death was caused by embryonic cell death that can be treated using Y 27632 dihydrochloride. Therefore, the rising incidence of infant mortalities is expected to drive the global Y 27632 dihydrochloride market.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment covered 

o By Type

o By Application

• Region covered

o North America

o Europe

o Asia-pacific

o Rest of world

• Competitive Landscape-  R&D Systems, Cayman Chemical, Tocris Bioscience, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Market Segmentation

Global Y 27632 Dihydrochloride Market is segmented by Type

o Low Purity (Below 97%)

o Purity (Above 97% and Below 99%)

o High Purity (Above 99%)

o Others

Global Y 27632 Dihydrochloride Market is segmented by Application

o Cancer Treatment

o Neurological Treatment

o Endocrinological Treatment

o Others

Global Y 27632 Dihydrochloride Market is segmented by Region